Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Octapharma seeks a Scientist (m/w/d) - R&D Product & Process Development in Vienna for a temporary assignment until 29.02.2028. You will develop and optimize production processes for blood plasma proteins and establish analytical methods for process and product characterization.
The ideal candidate holds a Master’s or PhD in natural sciences, with protein purification expertise and strong English and German skills, and will collaborate with internal teams and external partners.
Select how often (in days) to receive an alert:
Job ID: 64260
Location: Wien, AT
Job Level: Professionals
Job Category: Research and Development
Employment Type: Temporary employment
Become part of a vital chain and contribute to our common goal of making people’s lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
With over 1700 employees, the Octapharma site in Vienna is the largest production site, and successful research and development location.
This position is temporary until 29.02.2028.
Enjoy these attractive benefits! You can find all offers here: Benefits
The minimum gross salary according to the collective agreement (chemical industry) is EUR 4.355,55 based on 38 hours per week (full-time). As we strive to offer a salary that reflects your individual profile and qualifications, there is a willingness to pay above the minimum salary.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care.With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 200 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.